Advanced Enzyme Tech Quarterly Results for Trading Insights
In Mar 2026, Advanced Enzyme Tech (ADVENZYMES) reported revenue ₹211 Cr and net profit ₹45 Cr — revenue +19.9% YoY. For annual financials, live price and key ratios, visit Advanced Enzyme Tech share price chart.
ADVENZYMES Quarterly Results — Revenue, Profit & EPS Highlights
Advanced Enzyme Tech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore Advanced Enzyme Tech share price performance to track price trends across different timeframes.
- Revenue of ₹211 Cr in Mar 2026 (+8.2% vs Sept 2025, +19.9% vs Mar 2025)
- Net Profit of ₹45 Cr in Mar 2026 (+0.0% vs Sept 2025, +66.7% vs Mar 2025)
- EBITDA of ₹71 Cr in Mar 2026 (+1.4% vs Sept 2025)
- Operating Margin of 31.0% in Mar 2026 (-2.0pp vs Sept 2025)
- Earnings Per Share of ₹3.84 in Mar 2026 (-0.8% vs Sept 2025)
Advanced Enzyme Tech Quarterly Results — Revenue, EBITDA, Net Profit & EPS
ADVENZYMES quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 211 | 195 | 176 | 195 | 192 | 8.2% | 19.9% |
| Net Profit (₹ Cr) | 45 | 45 | 27 | 40 | 43 | - | - |
| EBITDA (₹ Cr) | 71 | 70 | 54 | 65 | 69 | - | - |
| EPS (₹) | 3.84 | 3.87 | 2.37 | 3.57 | 3.80 | - | - |
| Operating Margin (%) | 31.0% | 33.0% | 27.0% | 30.0% | 29.0% | - | - |
ADVENZYMES Share Price Trend — 1-Year Movement Across Quarterly Results
Advanced Enzyme Tech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Browse ADVENZYMES cash flow statement for revenue, profit, balance sheet and cash flow data.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
ADVENZYMES vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Advanced Enzyme Tech latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹454,122.13 Cr | 1904.8 | 15,018 | 2,710 | +1.0% | +11.8% | 18.0% | 168.6 |
|
Divis Laboratories
Mar 2026 |
₹174,081.02 Cr | 6757.0 | 2,986 | 751 | +4.4% | +11.8% | 25.2% | 238.7 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹161,380.94 Cr | 4768.3 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 414.3 |
|
Cipla
Mar 2026 |
₹117,800.00 Cr | 1458.2 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 212.3 |
|
Dr Reddys Laborator…
Mar 2026 |
₹114,691.88 Cr | 1374.1 | 7,996 | 221 | -12.5% | -11.5% | 2.8% | 518.5 |
All amounts in ₹ Crores